Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection

Abstract

Although residual morbidity for both treatment groups was evident, the results of the NSABP B-32 study indicate the superiority of the SLND compared to the ALND treatment approach relative to post-surgical morbidity outcomes over a 3-year follow-up period.